Physician profile
Man H Cho
NPI 1538470869
$8,092.63
in general payments reported to CMS, 2019-2025
17 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what 87% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $507 · 2021: $3,127 · 2022: $1,455 · 2023: $1,072 · 2024: $178 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,117 · Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,117.13 |
| Food and Beverage | $780.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $3,851.33 | 2020-2025 | |
| Arthrex, INC. | $3,471.43 | 2021-2025 | |
| Convatec INC. | $191.35 | 2023 | |
| Anika Therapeutics, INC. | $105.90 | 2022 | |
| Zimmer Biomet Holdings, INC. | $87.35 | 2022 | |
| Organogenesis INC. | $72.45 | 2019-2024 | Affinity |
| Stryker Corporation | $65.56 | 2019 | |
| Smith+Nephew, INC. | $42.51 | 2023-2024 | Grafix Pl, Evos Mini, Smart Tsf |
| Arteriocyte Medical Systems, INC. | $30.30 | 2024 | Magellan |
| Abbott Laboratories | $28.86 | 2022 | |
| Aroa Biosurgery Incorporated | $25.70 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $25.55 | 2025 | |
| Acera Surgical, INC. | $24.75 | 2021 | |
| Progenacare Global, LLC | $23.04 | 2024 | |
| Integra Lifesciences Corporation | $19.40 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $14.50 | 2019 | |
| Cashflow Solutions, LLC | $12.65 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Man Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.